Can B Corp (CANB)

[sleekscape]

MILE HIGH LABS HAS CHOSEN CBD ISOLATE


“Mile High Labs intends to concentrate on the manufacture of CBD isolates.”

That’s the final sentence of this article

Mile High Labs is one of Canbiola’s business partners

They are also the largest Hemp Processor in America and the largest CBD manufacturer in the world

They can process Hemp into Full Spectrum CBD, Broad Spectrum CBD and Pure CBD Isolate

So if they are shifting their focus to concentrate on making Pure CBD Isolate, then that’s yet another big clue on top of the ones we’ve already received from Dr. Gottlieb and Aurora Cannabis — the FDA will only be permitting Pure CBD Oil products to be sold nationally in their upcoming regulations

That tells you all you need know about where the CBD industry is heading in 2020

Full Spectrum (THC + CBG/CBN/CBC + CBD) and Broad Spectrum (CBG/CBN/CBC + CBD) are OUT

Pure CBD, also known as CBD Isolate (CBD), is IN

Pure CBD Oil products and Processing Hemp into CBD Isolate are the 2 biggest growth areas in the CBD Oil industry and CANB has put down roots in both

CANB is the only publicly traded company in the U.S. that is producing and selling a full line of Pure CBD Oil products

And they are also a grower of hemp and a processor of hemp into CBD Isolate, so CANB has the entire supply chain covered, which will bring costs down and maximize gross margins

I’ve been saying this for awhile now, the clues have been out there courtesy of Dr. Gottlieb

FDA WILL ONLY APPROVE PURE CBD (ISOLATE) FOR NATIONAL SALES:

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=151290678


Here is the relevant excerpt:

Mile High Labs unveiled its 400,000 square foot facility for hemp extraction in Broomfield, CO earlier this month. The facility was repurposed from drug manufacture and came replete with a suite of pharmaceutical manufacturing equipment. Mile High Labs intends to concentrate on the manufacture of CBD isolates.


Here is the full article:

https://www.nutraingredients-usa.com/Article/2019/10/17/UNPA-announces-hemp-policy-signs-up-first-CBD-member#

UNPA announces hemp policy, signs up first CBD member

The United Natural Products Alliance has announced a new policy on hemp extracts while at the same time announcing its first member engaged exclusively in the business.

Yesterday UNPA unveiled its new policy??. The quality and compliance criteria laid out in the new policy form the basis of UNPA’s membership criteria for both new and current Executive-level members.

“While efforts at the state and federal level to clarify the legal status of hemp extract and cannabinoid products continue, UNPA believes it is in the interest of consumers, health professionals and relevant industries to establish a framework of practices and compliance standards for hemp extract/cannabinoid products,” said Loren Israelsen, UNPA president.

Policy details

The new policy requires new hemp members to agree to the following as part of their membership application:

Compliance assessment
Website review
Label/labeling (may include packaging, printed literature, websites, social media, etc.)
UNPA staff & Executive Committee review & vetting.
UNPA also drew a bright line in the sand that the policy applies to hemp derived ingredients only. Companies making synthetic cannabinoids will not be eligible for membership.
The policy also includes numerous provisions on things such as adverse event reporting, recall procedures, FTC claims compliance and others.

The first hemp member is Mile High Labs whose membership was announced today at a breakfast meeting at the SupplySide West trade show in Las Vegas, NV.

Mile High Labs unveiled its 400,000 square foot facility for hemp extraction in Broomfield, CO earlier this month. The facility was repurposed from drug manufacture and came replete with a suite of pharmaceutical manufacturing equipment. Mile High Labs intends to concentrate on the manufacture of CBD isolates.


Sleek